Prospective study of restless legs syndrome and coronary heart disease among women
- PMID: 22967852
- PMCID: PMC3493117
- DOI: 10.1161/CIRCULATIONAHA.112.112698
Prospective study of restless legs syndrome and coronary heart disease among women
Abstract
Background: Previous cross-sectional studies suggested a positive association between restless legs syndrome (RLS) and coronary heart disease (CHD). This observation was not confirmed by subsequent prospective studies. However, these prospective studies did not take into account the duration of RLS symptoms. Therefore, we prospectively examined whether RLS was associated with an increased risk of CHD in women who participated in the Nurses' Health Study, taking into account the duration of RLS symptoms.
Methods and results: A total of 70 977 women (mean age, 67 years) who were free of CHD and stroke at baseline (2002) were followed up until 2008. Physician-diagnosed RLS was collected via questionnaire. CHD was defined as nonfatal myocardial infarction or fatal CHD. Women with RLS at baseline had a marginally higher risk of developing CHD (multivariable-adjusted hazard ratio, 1.46; 95% confidence interval, 0.97-2.18) compared with women without RLS. The risk was dependent on duration of symptoms: 0.98 (95% confidence interval, 0.44-2.19) for women with RLS for <3 years and 1.72 (95% confidence interval, 1.09-2.73) for women with RLS for ≥3 years (P trend=0.03). The multivariable-adjusted hazard ratios of women with RLS for ≥3 years were 1.80 (95% confidence interval, 1.07-3.01) for nonfatal myocardial infarction and 1.49 (95% confidence interval, 0.55-4.04) for fatal CHD relative to women without RLS.
Conclusions: We observed that women with RLS for at least 3 years had an elevated risk of CHD. These results suggest that RLS or RLS-associated conditions may contribute to the origin of cardiovascular disease.
Conflict of interest statement
A.S.W receives research grant from UCB and CME sponsored honorarium, and holds consultancy/advisory board relationship with UCB.
J.W.W holds consultancy/advisory board relationship with Pfizer, UCB, Zeo, Sunovion and ownership interest with Zco, and receives research grant from GlaxoSmithKline Impax Pharmaceuticals.
Other authors have indicated no financial conflicts of interest.
Similar articles
-
Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.Sleep. 2015 Jul 1;38(7):1009-15. doi: 10.5665/sleep.4800. Sleep. 2015. PMID: 26083613 Free PMC article.
-
Prospective study of restless legs syndrome and risk of depression in women.Am J Epidemiol. 2012 Aug 15;176(4):279-88. doi: 10.1093/aje/kws016. Epub 2012 Jul 17. Am J Epidemiol. 2012. PMID: 22805376 Free PMC article.
-
Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study.Neurology. 2008 Jan 1;70(1):35-42. doi: 10.1212/01.wnl.0000287072.93277.c9. Neurology. 2008. PMID: 18166705
-
Prospective study of obesity, hypertension, high cholesterol, and risk of restless legs syndrome.Mov Disord. 2014 Jul;29(8):1044-52. doi: 10.1002/mds.25860. Epub 2014 Apr 21. Mov Disord. 2014. PMID: 24753235 Free PMC article.
-
Social Integration and Reduced Risk of Coronary Heart Disease in Women: The Role of Lifestyle Behaviors.Circ Res. 2017 Jun 9;120(12):1927-1937. doi: 10.1161/CIRCRESAHA.116.309443. Epub 2017 Apr 3. Circ Res. 2017. PMID: 28373350 Free PMC article.
Cited by
-
Effect of nighttime aircraft noise exposure on endothelial function and stress hormone release in healthy adults.Eur Heart J. 2013 Dec;34(45):3508-14a. doi: 10.1093/eurheartj/eht269. Epub 2013 Jul 2. Eur Heart J. 2013. PMID: 23821397 Free PMC article. Clinical Trial.
-
Plasma apelin level in patients with restless legs syndrome and its association with periodic leg movements.Sleep Breath. 2017 Mar;21(1):19-24. doi: 10.1007/s11325-016-1355-7. Epub 2016 May 19. Sleep Breath. 2017. PMID: 27193873
-
Association of Restless Legs Syndrome With Risk of Suicide and Self-harm.JAMA Netw Open. 2019 Aug 2;2(8):e199966. doi: 10.1001/jamanetworkopen.2019.9966. JAMA Netw Open. 2019. PMID: 31441941 Free PMC article.
-
Caenorhabditis elegans and its applicability to studies on restless legs syndrome.Adv Pharmacol. 2019;84:147-174. doi: 10.1016/bs.apha.2018.12.003. Epub 2019 Mar 14. Adv Pharmacol. 2019. PMID: 31229169 Free PMC article. Review.
-
Cardiac Involvement in Movement Disorders.Mov Disord Clin Pract. 2021 Apr 7;8(5):651-668. doi: 10.1002/mdc3.13188. eCollection 2021 Jul. Mov Disord Clin Pract. 2021. PMID: 34307738 Free PMC article. Review.
References
-
- Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, Ferini-Strambi L. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165:1286–1292. - PubMed
-
- Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32:1484–1492. - PubMed
-
- Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12:61–65. - PubMed
-
- Ali NJ, Davies RJ, Fleetham JA, Stradling JR. Periodic movements of the legs during sleep associated with rises in systemic blood pressure. Sleep. 1991;14:163–165. - PubMed
-
- Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, Rundle AG, Zammit GK, Malaspina D. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006;47:833–839. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical